This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

The JAK-STAT Pathway in Inflammatory Bowel Disease—Expert Insights and Discussion of the Latest Research

The JAK-STAT Pathway in Inflammatory Bowel Disease—Expert Insights and Discussion of the Latest Research

Format

Expert Perspective

Time to Complete

1 hour

Released

June 28, 2017

Expires

June 27, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

This activity is supported by an independent educational grant from Pfizer.

Program Description

Russell D. Cohen, MD, and Thomas A. Ullman, MD, summarize clinical data on JAK inhibitors in inflammatory bowel disease (IBD). In addition to discussing the rationale for targeting Janus kinase (JAK)-STAT signaling pathways, faculty discuss the clinical implications of new research for patients with IBD.

Intended Audience

This activity was developed for gastroenterologists, gastroenterology fellows, and other health care providers who manage patients with inflammatory bowel disease.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Describe the relationship between the Janus Kinase-STAT signaling pathway and pathogenesis of inflammatory bowel disease
  • Summarize the latest research developments in treatment of inflammatory bowel disease with Janus Kinase (JAK) inhibitors
  • Incorporate evidence-based research into clinical practice

Conflict Of Interest Disclosure Policy

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

Russell D. Cohen, MD
Professor of Medicine, Pritzker School of Medicine
Director, Inflammatory Bowel Disease Center
Co-Director, Advanced IBD Fellowship Program
The University of Chicago Medicine
Chicago, Illinois

Dr. Cohen discloses the following:
Research Support: Astra-Zeneca, Celgene, Gilead Sciences, MedImmune, Mesoblast Ltd, Osiris Therapeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, UCB Pharma
Consultant: AbbVie Laboratories, Celgene, Eli Lilly, Hospira, Janssen, Pfizer, Sandoz Biopharmaceuticals, Takeda, UCB Pharma
Speakers Bureau: AbbVie, Takeda

Thomas A. Ullman, MD
Senior Associate Dean for Clinical Affairs
Professor of Medicine
The Dr. Henry D. Janowitz Division of Gastroenterology
Chief Medical Officer
Mount Sinai Doctors Faculty Practice
Icahn School of Medicine at Mount Sinai
New York, New York

Dr. Ullman discloses the following:
Consultant: American Regent

Planners and Managers Disclosures

Annenberg Center for Health Sciences
John Bayliss, VP
, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Additional content planners
The following have no significant relationship to disclose:
Eugene A. Cullen, MD (peer reviewer)
Alexandra Howson, PhD (medical writer)

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The faculty for this activity has disclosed that there will be discussion about the use of products for non-FDA approved indications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue